Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Heimstaden Issues EUR 400m Senior Unsecured Bond

Heimstaden AB yesterday successfully issued a EUR 400 million fixed rate senior unsecured bond under its MTN programme with a maturity of 5.5 years. The bond carries an annual coupon of 4.375% and a yield of 4.500%. An application will be made for the bond to be listed on Nasdaq Stockholm. The final listing particulars, once published, will be made available on www.heimstaden.com. J.P. Morgan and Swedbank acted as Joint Bookrunners for the issue.  Contact:Arve Regland, CFO+47 47 90 77 00arve.regland@heimstaden.com Adam Lindh, Head of Treasury+46 708-83 96 74adam.

Holmström Fastigheter Holding’s subsidiary F Holmström Holding 6 AB completes the public offer to the sharesholders of Magnolia Bostad

F Holmström Holding 6 AB, reg.no. 559279-7376 (“FHH”), a company which together with inter alia Holmström Fastigheter Holding AB (publ), reg.no. 559286-6809 (“Holmström Holding”) is included in Holmströmgruppen, announced on 7 July 2021 a recommended cash offer to the shareholders of Magnolia Bostad AB, reg.no. 556797-7078 (“Magnolia Bostad” or “the Company”) to tender all of their shares in Magnolia Bostad to FHH (the “Offer”). FHH has today announced the outcome after the extended acceptance period and that the Offer is completed. Furthermore, FHH has announced an offer to acquire

Scandinavian ChemoTech is carrying out a directed new share issue and will receive approximately MSEK 18

Scandinavian ChemoTech AB (publ) (“ChemoTech” or “the Company”) hereby announces that the Company has carried out a directed new share issue which will provide the Company with approximately MSEK 18 before transaction costs. The capital injection enables an upshift of the Company's long-term strategy.The Board of ChemoTech has, with the support of authorisation from the Annual General Meeting on May 24, 2021, decided on a directed new issue of 874,211 Series B shares at a subscription price of SEK 20.59 per share. The subscription price corresponds to a discount of approximately 15 percent

BoMill’s long-term incentive program for employees fully subscribed

On May 6, 2021, the Annual General Meeting of BoMill AB resolved on an long-term incentive program through a directed issue of 200,000 warrants of series B 2021-2024 that entitles senior executives and other employees of BoMill the right to subscribe for new shares in the company. The last day for subscription of warrants was August 30, 2021, and the directed issue of warrants was fully subscribed.The purpose of the incentive program is to strengthen the employees of the company´s interest and incentives for the company’s financial growth. The rights to subscribe were offered to the CEO and

Lipum’s toxicology- and safety studies on the candidate drug SOL-116 progress according to plan

Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum’s candidate drug (SOL-116) have been completed according to plan and the final Clinical Trial Application (CTA)-enabling toxicology study has now started.The non-clinical program for toxicology- and safety studies of Lipum’s candidate drug (SOL-116) is carried out in collaboration with the contract research organisation (CRO) Charles River Laboratories. Previous dose finding studies, which included various dose levels, were conducted in two different species with a treatment period of four weeks.

Realheart enters partnership with software experts Codialist

Realheart's artificial heart consists of two parts: an internal heart unit and an external control unit that is the brain of the system. The control unit software is now being tested to develop the final version in preparation for human clinical trials. This is being done in collaboration with medical device software experts Codialist.Codialist is a software development firm for medical devices with special expertise in heart pump technologies having been spun off from Berlin Heart GmbH, a world-leading German manufacturer of assistive devices for patients with end-stage heart failure.

Record date for the allotment of warrants of series TO3 to shareholders in Wyld Networks AB

As Wyld Networks AB (”Wyld Networks” or the "Company") communicated on August 24, 2021 the board of directors decided to issue warrants of series TO3 (the “Warrants”) to the current shareholders of Wyld Networks who on the record date, September 8, 2021, holds shares in the Company.The record date to receive warrants of series TO3 has been set to September 8, 2021. Therefore, the last day of trading in the Company’s share including the right to receive warrants of series TO3 is September 6, 2021, and the first day of trading in the Company’s share excluding the right to receive warrants of

Sectra’s three-month interim report 2021/2022: Early deliveries have a positive effect on the period—not expected to affect the full year

Press release – Linköping, September 3, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has significant variations in financial outcomes between periods and its earnings have traditionally been low during the first quarter of the year. This year, some deliveries, primarily in the US, were carried out earlier than planned and operating profit subsequently increased to SEK 90.1 million, which is high for a first quarter. This strong start to the year is not expected to affect the company’s outcome for the fiscal year as a

Receipt of regulatory approval from the NFSA regarding the recommended voluntary cash offer for all outstanding shares in Bank Norwegian ASA

NOT FOR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA AND JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE PRIOR APPROVAL. FOR MORE INFORMATION ABOUT NORDAX'S VOLUNTARY OFFER, PLEASE SEE NORDAX'S FORMAL OFFER ANNOUNCEMENT, AVAILABLE AT: WWW.COLLABORATE-TO-SCALE.COM.Reference is made to the offer document dated 5 August 2021 (the "Offer Document") and the stock exchange announcement on the same day for the recommended voluntary offer by Nordax Bank AB (publ) ("Nordax" or the "Offeror") to acquire all outstanding shares (the "Shares") in Bank

XNK Therapeutics appoints Markus Thor as Chief Business Officer

Sept. 3, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Markus Thor as Chief Business Officer, effective September 6[th]. He will be member of the company’s management team. Mr. Thor is an experienced business development executive with 25 years’ experience from the life science industry. In previous roles he was responsible for structuring, negotiating and closing a range of global, strategic business agreements, including in- and out-licensing, acquisitions and R&D collaborations. Prior to joining XNK, Mr. Thor worked more than a decade at Biovitrum AB,

CapMan Real Estate acquires industrial property in Köping

CapMan Real Estate Press Release3 September 2021 at 09:00 a.m. EEST CapMan Real Estate acquires industrial property in Köping CapMan Nordic Real Estate Fund III has agreed to acquire a property in Köping by entering into a sale and leaseback agreement for four years. The property consists of approximately 60,000 sqm of land and 35,000 sqm of industrial and storage space. The location in Köping is favourable from a logistics point of view. This is the second industrial asset which CapMan Nordic Real Estate acquires in the Mälardalen area as it bought the Assa lock

Notice of Annual General Meeting of Flexion Mobile Plc

If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice from your stockbroker or other independent adviser authorised under the Financial Services and Markets Act 2000. Notice of Annual General Meeting FLEXION MOBILE PLC Notice is hereby given that the 2021 annual general meeting ("AGM") of Flexion Mobile Plc ("Company") will be held at Flexion Mobile Plc, Unit G5, Harbour Yard, Chelsea Harbour, London, SW10 0XD, UK on 29[th]  September 2021 at 2.00 pm.  You will be asked to consider and vote on the resolutions below. Of

Lambi introduces new easy-to-use Home Towel household sheets

Lambi, a brand of Metsä Tissue, launches the new, easy-to-use Home Towel household sheets to ease the life of those who value functionality, high quality and design. One Lambi Home Towel package has the same amount of paper as two and a half regular household kitchen rolls. The conveniently folded, individual sheets can be used with a single hand. One sheet at a time.Household sheets are a great helper in the everyday life and they bring the convenience of household paper to the next level. Thanks to the compact form of the product, it requires less storage space and most importantly, it is

Peab builds a parking garage and office space in Turku

Peab has been commissioned to build a parking garage and commercial space in Turku. The customer is Reale Rakennus Oy and Litu Oy and the contract is worth EUR 15 million.Peab has been commissioned to build a parking garage and commercial space in Turku. The customer is Reale Rakennus Oy and Litu Oy and the contract is worth EUR 15 million. The project entails building an underground two level parking garage, commercial space on the ground floor and offices on the second. The new complex will also be the foundation for four new future apartment buildings that will be built on top of it.

First Episealer® Talus surgery planned in Spain

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Spain has been scheduled. “We are continuing to execute on our international strategy, and I am pleased with having the first Episealer® Talus surgery in Spain scheduled. This also means that during 2021, we have had customers in 15 countries globally. Given that we are still early on our development curve, I believe that says something about our level om ambition”, says Pål Ryfors, CEO Episurf Medical.

Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria

03 September 2021 07:00 BST Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria Approval based on interim results from Phase III trial demonstrating complete terminal complement inhibition with reduced dosing frequency compared to Soliris Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children (with a body weight of 10 kg or above) and adolescents with paroxysmal nocturnal haemoglobinuria (PNH), an ultra-rare and severe blood disorder characterised by the destruction of red blood cells that

Composition of Valmet’s Nomination Board

Composition of Valmet’s Nomination Board Valmet Oyj’s stock exchange release on September 3, 2021 at 9:00 a.m. EEST According to Valmet Oyj’s Annual General Meeting’s decision, Valmet’s Nomination Board consists of the representatives of Valmet’s four largest shareholders as of September 1, and the Chairman of the Board of Directors as an expert member. Should a shareholder not wish to exercise his/her nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member. Based on the shareholder register of

Klaus Toft Nørgaard appointed Chief Business Development Officer for LMK Group

LMK Group today announced the appointment of Klaus Toft Nørgaard, currently Managing Director for RetNemt brand in Denmark, as Chief Business Development Officer for LMK Group. The appointment takes place in connection with the integration of the RetNemt operations, expected to be completed during Q4 2021. In his new role, Klaus will manage new business development initiatives on Group level.Klaus is the founder of RetNemt, which was acquired by LMK Group in 2016. He has been a member of the group management team since then. “I’m happy to welcome Klaus as CBDO. In this role, Klaus will

DSRT: H1 2021 Report and Financial Results | Desert Control AS

ISSUER DESERT CONTROL AS DSRT: H1 2021 Report and Financial Results | Desert Control ASStavanger, Norway, 3 September 2021 – Desert Control AS (DSRT) today announcedits H1 Report and Financial Results for the fiscal first half of 2021, ending 30June 2021.Desert Control is a company specialized in climate-smart agri-tech solutions tocombat desertification, soil degradation, and water scarcity. Its patentedLiquid Natural Clay (LNC) restores and protects soil, reducing water usage foragriculture, forests, and green landscapes.Desert Control continued focused execution to

Elisa’s Earnings Releases and AGM in 2022

ELISA STOCK EXCHANGE RELEASE 3 SEPTEMBER 2021 AT 8:00 AMIn 2022 Elisa will publish its financial results statement, half year financial report and interim reports as follows: · 27 January 2022: Financial results for 2021 · 22 April 2022: Interim report Q1 2022 · 15 July 2022: Half year financial report 2022 · 19 October 2022: Interim report Q3 2022 Elisa's Annual General Meeting is planned to be held on 6 April 2022.  ELISA CORPORATION Vesa SahivirtaIR Director+358 50 520 5555 Distribution: Nasdaq HelsinkiPrincipal Mediaelisa.com 

Kemira invests in a new production line of ASA sizing agents in Asia-Pacific for paper and board industry

Press release, September 3rd 2021 at 08:00 EESTKemira, a global leader in sustainable chemical solutions for water intensive industries, announces a significant investment in the production of alkenyl succinic anhydride sizing agent (ASA) in China. ASA is one of the most effective and cost-efficient sizing agents for improving water-resistance in paper and packaging board. This investment into an additional, third production line at the company’s state-of-the-art Nanjing site in the Jiangsu province, will expand Kemira’s ASA production capacity substantially. Earlier this year, Kemira

IRISITY CARRIES OUT A DIRECTED NEW SHARE ISSUE OF SEK 130 MILLION, CONDITIONAL ON APPROVAL FROM THE EXTRAORDINARY SHAREHOLDERS’ MEETING.

Irisity AB (publ) (”Irisity” or the ”Company”) has resolved on a directed new share issue of 2,700,000 shares conditional on approval granted by the extraordinary shareholders’ meeting (the "Directed New Share Issue"). The subscription price of the shares in the Directed New Share Issue amounts to SEK 49 per share. Through the Directed New Share Issue, Irisity will receive proceeds amounting to approximately SEK 130 million before deduction of transaction costs. The issue proceeds will be used as part of the financing of the acquisition of Agent Video Intelligence Ltd (“Agent”) (the “

ShaMaran June 2021 Payments Received

September 2, 2021, VANCOUVER, BC /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (SNM: TSXV and Nasdaq First North Growth Market (Sweden)) confirms receipt of payment for the June 2021 Atrush sales and entitlements at $26.6 million ($9.8 million net to the Company).  The Company is also in receipt of $1.8 million net to the Company as the next instalment for June 2021 in the Kurdistan Regional Government (“KRG”) receivable repayment mechanism calculated based on the KRG's proposed amendment to the mechanism repayment terms as announced on May 13, 2021.  Today’s payment

Panoro Energy – Hibiscus North Exploration Well Result

Oslo, 2 September 2021 – Panoro Energy ASA (“Panoro”) today announces that drilling operations have concluded at the Hibiscus North exploration well (DHBNM-1) on the Dussafu Marin Permit offshore Gabon ("Dussafu"). Following the announcement on 24 August 2021 that the well had encountered oil-bearing reservoir in the Upper Gamba Sandstone which was the primary target, drilling continued to a measured depth of approximately 3,336 metres. Oil bearing sands were also encountered in the deeper Dentale formation with variable reservoir quality. The Dussafu JV partners have determined that

There are no items matching the current filter
There are no more items matching the current filter
Back to top